OLOPATADINE HYDROCHLORIDE - Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3)

Manufacturer
Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3)
Effective date
2026-11-04
Label type
Human OTC Drug Label
Version
1
Source
daily-update
Hydrated at
2026-11-10 04:06:37

Label at a glance#

ProductOLOPATADINE HYDROCHLORIDE
Active ingredientOLOPATADINE HYDROCHLORIDE
Label structure13 sections

Dosage and administration

adults and children 2 years of age and older: put 1 drop in the affected eye(s) once daily do not use more than 1 drop in each eye per day if using other ophthalmic products while using this product, wait at least 5 minutes between each product replace cap after each use children under 2 years of age: consult a doctor

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Olopatadine (0.7%)…………..(equivalent to olopatadine hydrochloride 0.776%)

PURPOSE

OTC - PURPOSE SECTION

Antihistamine

INDICATIONS & USAGE

INDICATIONS & USAGE SECTION

Use temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander

WARNINGS

WARNINGS SECTION

For external use only

DO NOT USE

OTC - DO NOT USE SECTION

  • if solution changes color or becomes cloudy
  • if you are sensitive to any ingredient in this product
  • to treat contact lens related irritation

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

  • do not touch tip of container to any surface to avoid contamination
  • remove contact lenses before use
  • wait at least 10 minutes before reinserting contact lenses after use
  • do not wear a contact lens if your eye is red

STOP USE

OTC - STOP USE SECTION

Stop use and ask a doctor if you experience:

  • eye pain
  • changes in vision
  • increased redness of the eye
  • itching worsens or lasts for more than 72 hours.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

  • adults and children 2 years of age and older:
    • put 1 drop in the affected eye(s) once daily
    • do not use more than 1 drop in each eye per day
    • if using other ophthalmic products while using this product, wait at least 5 minutes between each product
    • replace cap after each use
  • children under 2 years of age: consult a doctor

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

  • only for use in the eye
  • store between 2° to 25°C (36° to 77°F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

benzalkonium chloride 0.015% (preservative), boric acid, hydrochloric acid/sodium hydroxide (to adjust pH), hydroxypropylgamma-cyclodextrin, hypromellose, mannitol, polyethylene glycol 400, povidone, and water for Injection.

QUESTIONS?

SPL UNCLASSIFIED SECTION

In the U.S., Contact Alembic Pharmaceuticals, Inc. at 1-866-210-9797.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Olopatadine Hydrochloride Ophthalmic Solution, USP 0.7% - Bottle Label

bottle-label-aplbottle-label-apl

Olopatadine Hydrochloride Ophthalmic Solution, USP 0.7% - Carton Label

bottle-carton-aplbottle-carton-apl

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeDataBar Limited(01)00346708774257GTIN-14: 00346708774257
GTIN-12: 346708774257
UPC-A: 346708774257
EAN-13: 0346708774257
GTIN storage (14 digits): 00346708774257
bottle-carton-apl.jpg
BarcodeDataBar Stacked(01)00346708774257GTIN-14: 00346708774257
GTIN-12: 346708774257
UPC-A: 346708774257
EAN-13: 0346708774257
GTIN storage (14 digits): 00346708774257
bottle-label-apl.jpg

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
46708-77446708-774-25

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A217856-001OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-11-03

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A217856-001OLOPATADINE HYDROCHLORIDEEQ 0.7% BASESOLUTION/DROPS / OPHTHALMIC2026-11-03d4dbc9d85df4…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OLOPATADINE HYDROCHLORIDEOLOPATADINE HYDROCHLORIDEAlembic Pharmaceuticals Limitede097611b-5b2d-471a-8bce-81ffbe9e58a52026-11-04WarningsExact identifier
ndc (package): 46708-774-25
ndc (product): 46708-774
ndc11 (package): 46708077425
spl id: e097611b-5b2d-471a-8bce-81ffbe9e58a5
spl set id: e097611b-5b2d-471a-8bce-81ffbe9e58a5

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.